12
Life Sciences Trend Analysis 2013 SWITZERLAN D

Life Sciences Trend Analysis 2013 SWITZERLA ND. About Us The following statistical information has been obtained from Biotechgate. Biotechgate is a global,

Embed Size (px)

Citation preview

Life Sciences Trend Analysis 2013

SWITZERLAND

About Us

The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com

The Swiss Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with Swiss Biotech Association, Biotechnet, BaselArea, Life Sciences Zurich, and SIX Swiss Exchange. www.swisslifesciences.com

Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.com

Status of the Sector

2012 Statistics

Switzerland 2013 Statistics

318 Total Biotech Companies 345

95 Biotech - Therapeutics 102

163 Biotech - R&D Services 178

60 Biotech - Other 65

94% Percentage of SME's 89%

4% Percentage of Publicly Owned Companies 4%

USD 159 M in 2011

Financing/Capital RaisedUSD 117 M in

2012

122 Licensing Opportunities 171

Key Activities of Biotechnology Companies

Historical DataSubsector 201

3201

2Bioinformatics & Bioelectronics

5% 5%

Contract Research & Manufacturing

14% 13%

Diagnostics and Analytical Services

20% 20%

Genomics & Proteomics 5% 5%Other Services and Suppliers 24% 25%Therapeutics 16% 16%Other 16% 16%

Bioinformatics and Bioelec-

tronics5%

Contract Re-search and

Manufacturing14%

Diagnostics and Analytical

Services20%

Genomics and Pro-teomics

5%

Other Services and Suppliers

24%Therapeutics

17%

Other17%

2013 Data

Company Foundation Timeline

19951996

19971998

19992000

20012002

20032004

20052006

20072008

20092010

20112012

20130

5

10

15

20

25

1 24 4 3

5 5 63

119 9

7 8

2

64

1

7

9

10

7 8

96 4

6

8

64

33

1

2

1

1

1

1

3

2 3

3

12

1

3

Biotechnology - Therapeutics and DiagnosticsBiotechnology / R&D ServicesBiotechnology - other

Year

No.

of

Com

panie

s F

ounded

Company Ownership

Historical DataSubsector 201

32012

Private/ Independent

79% 81%

Public 4% 4%Subsidiary 17% 15%

Private / in-dependent

79%

Public4%

Sub-sidiary17%

2013 Data

Sources of Company Foundations

Historical DataCompany Foundation 2013 2012Independent foundation 44% 50%Merger 1% 2%Spin-off from company 3% 4%Spin-off from public institution / NPO 2% 2%Spin-off from university 15% 22%Subsidiary 14% 14%Other 5% 5%

Undisclosed16%

Independent foundation

44%

Merger1%

Spin-off from company

3%

Spin-off from public institu-

tion / NPO2%

Spin-off from university

15%

Subsidiary13%

Other5%

2013 Data

Number of Employees

Historical DataNo. of Employees 2013 20121-10 34% 33%11-50 40% 44%51-200 15% 17%Greater than 200 11% 6%

1-10:34%

11-50:40%

51-200:15%

201+:11%

2013 No. of Employees

Products in the Pipeline

2013

2012

2013

2012

2013

2012

2013

2012

Pre

clin

ical

Phase

IPhase

II

Phase

III

0 20 40 60 80 100 120 140

115

123

53

41

49

45

25

14

No. of Products

Financing Rounds in Switzerland & 3 Major Financing Rounds

Financing for 2012/2013 Private Biotech Companies

Major Financings in 2012/2013

SectorUSD M

Biocartis SABiotech – Therapeutics &

Diagnostics45

GenKyoTex SABiotech – Therapeutics &

Diagnostics27

PIQUR Therapeutics Ltd.Biotech – Therapeutics &

Diagnostics15

2007 2008 2009 2010 2011 20120

50100150200250

0

4

8

12

Financing ValueNumber of Financings

Half Yearly

Fin

an

cin

g V

alu

e

US

D M

Nu

mb

er

of

Fu

nd

ing

R

ou

nd

s

About Biotechgate

Biotechgate contains over 29’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data.

To register for free or learn more about the different subscription options, please visit www.biotechgate.com.

Terms of Use

The “Swiss Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof.

The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions.

Biotechgatec/o Venture Valuation VV AGKasernenstrasse 11 +41 (43) 321 86 608004 Zurich [email protected] www.venturevaluation.com